Autres langues

25/06 Induct AS: Publication of company presentation
19/06 Induct Plans Up to NOK20 Million Capital Raise Via Underwritten Rights Issue
15/06 Induct : Invitation to company presentation
29/05 Induct : Annual Report 2025 – Events after the balance sheet date
13/05 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2026
16/02 Induct : Finansiell kalender
12/02 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
13/11 Induct AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
20/10/25 Induct notifies regulator of possible market abuse violations
22/09/25 Induct : Meldepliktig handel for primærinnsider – Styremedlem og største aksjonær øker eierandelen
14/08/25 Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
14/08/25 Induct Q2 Ebitda Nok 3.3 Mln
14/08/25 Induct : Interim Report Q2 2025
18/07/25 Induct CFO steps down
07/07/25 Induct Raises NOK6 Million in Private Placement to Reduce Debt
07/07/25 Induct completes private placement
27/05/25 Induct, Norne Securities Enter Into Market Making Agreement
23/05/25 AstraZeneca Expedites Care Pathway System Commercialization Talks With Induct
23/05/25 Induct: Astrazeneca Starts Commercial Discussions Earlier Than Planned
23/05/25 Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned
24/04/25 Management Software Developer Induct Raises NOK14.5 Million from Share Sale
10/04/25 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2025
10/04/25 Induct Q1 EBITDA Rises To NOK 3.0 Mln
05/03/25 Induct Says Hittabidrag Signs Its First Municipal Agreement
13/02/25 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
Aucun résultat pour cette recherche